A composition comprising a mixture of (a) a recombinant protein comprising a listeriolysin O (LLO) protein comprising a mutation within the cholesterol-binding domain (CBD) thereof, and wherein the recombinant protein exhibits a greater than 100-fold reduction in hemolytic activity relative to a wild-type LLO protein; and (2) an antigenic peptide.